Quick Answer
Arcus Biosciences, Inc. reported Operating Income of -$386.00 million for fiscal year 2025.
Arcus Biosciences, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$386.00M | -17.0% |
| 2024 | -$330.00M | +2.9% |
| 2023 | -$340.00M | -21.4% |
| 2022 | -$280.00M | -618.5% |
| 2021 | $54.00M | +143.5% |
| 2020 | -$124.00M | -39.8% |
| 2019 | -$88.71M | -61.7% |
| 2018 | -$54.86M | -2.7% |
| 2017 | -$53.44M | -193.9% |
| 2016 | -$18.18M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$142.00M | -35.2% | -1675.0% |
| June 30, 2025 | -$8.00M | +92.5% | +93.4% |
| March 31, 2025 | -$122.00M | -662.5% | -16.2% |
| September 30, 2024 | -$105.00M | -31.2% | +0.9% |
| June 30, 2024 | -$106.00M | -27.7% | -562.5% |
| March 31, 2024 | -$16.00M | +81.4% | +80.0% |
| September 30, 2023 | -$80.00M | -14.3% | +3.6% |
| June 30, 2023 | -$83.00M | -20.3% | +3.5% |
- Arcus Biosciences, Inc. showed a decrease of -17.0% in Operating Income compared to the prior fiscal year.
- Over the 2016–2025 period, Arcus Biosciences, Inc.’s operating income has declined by 2023.0% (from -$18.18 million to -$386.00 million).
- The most recent figure is from Arcus Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: